Art Therapy Clinical Trials

6 recruitingLast updated: June 18, 2026

There are 6 actively recruiting art therapy clinical trials across 5 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Bern, Switzerland, Jeddah, Mecca Region, Saudi Arabia, Konya, Karatay, Turkey (Türkiye). Updated daily from ClinicalTrials.gov.


Art Therapy Trials at a Glance

6 actively recruiting trials for art therapy are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Bern, Jeddah, and Konya. Lead sponsors running art therapy studies include King Abdulaziz University, Peter MacCallum Cancer Centre, Australia, and Ruijin Hospital.

Browse art therapy trials by phase

Treatments under study

About Art Therapy Clinical Trials

Looking for clinical trials for Art Therapy? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Art Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Art Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

The Effect of Art-Based Nursing Intervention Helping to Develop Healthy Digital Habits on Digital Addiction, Cyberbullying and Self-Efficacy in Adolescents

CyberbullyingSelf EfficacyAdolescence+2 more
Selcuk University64 enrolled1 locationNCT07123194
Recruiting

Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)

Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific Antibody+1 more
University of Zurich208 enrolled2 locationsNCT07309497
Recruiting
Not Applicable

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

LeukemiaTransplantation, Stem CellCART Therapy+1 more
Peter MacCallum Cancer Centre, Australia214 enrolled2 locationsNCT07051525
Recruiting
Phase 3

Art-Based Pain Assessment Tool in Patients With Temporomandibular Joint Disorders

Temporomandibular Disorders (TMD)Wilkes 1 and 2TMJ Pain+3 more
King Abdulaziz University70 enrolled1 locationNCT07018791
Recruiting
Phase 2

Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL

CART TherapyB-NHL
Ruijin Hospital144 enrolled1 locationNCT06695013
Recruiting
Phase 1

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

CART TherapyNK/T-cell LymphomaCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology10 enrolled1 locationNCT06732492